VYNE Therapeutics Inc. Quarterly Return On Assets in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
VYNE Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q3 2018 to Q3 2024.
  • VYNE Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -38.6 %, a 64% increase year-over-year.
  • VYNE Therapeutics Inc. annual Return On Assets for 2023 was -64.2 %, a 43.3% decline from 2022.
  • VYNE Therapeutics Inc. annual Return On Assets for 2022 was -44.8 %, a 34.1% increase from 2021.
  • VYNE Therapeutics Inc. annual Return On Assets for 2021 was -68 %, a 67.2% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -38.6 +68.5 +64% Jul 1, 2024 Sep 30, 2024
Q2 2024 -38.5 +56.4 +59.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -49.8 +25.4 +33.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -64.2 -19.4 -43.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -107 -64.6 -152% Jul 1, 2023 Sep 30, 2023
Q2 2023 -94.9 -40.2 -73.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -75.2 -19.7 -35.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -44.8 +23.2 +34.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.6 +31.6 +42.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -54.7 +18.2 +25% Apr 1, 2022 Jun 30, 2022
Q1 2022 -55.5 +140 +71.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -68 +139 +67.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -74.2 +137 +64.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -72.9 +142 +66.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -196 -104 -113% Jan 1, 2021 Mar 31, 2021
Q4 2020 -207 -132 -175% Oct 1, 2020 Dec 31, 2020
Q3 2020 -211 -149 -237% Jul 1, 2020 Sep 30, 2020
Q2 2020 -215 -167 -346% Apr 1, 2020 Jun 30, 2020
Q1 2020 -91.8 -55.1 -150% Jan 1, 2020 Mar 31, 2020
Q4 2019 -75.4 -43.4 -135% Oct 1, 2019 Dec 31, 2019
Q3 2019 -62.8 -32.5 -107% Jul 1, 2019 Sep 30, 2019
Q2 2019 -48.3 Apr 1, 2019 Jun 30, 2019
Q1 2019 -36.7 Jan 1, 2019 Mar 31, 2019
Q4 2018 -32 Oct 1, 2018 Dec 31, 2018
Q3 2018 -30.3 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.